IRCT20200420047147N2招募中3 期
Study of the effect of dipeptidyl peptidase 4 inhibitors on the improvement rate and prognosis of diabetic patients with Covid-19
Artesh University of Medical Sciences0 个研究点目标入组 70 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 70
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Patients who have been diagnosed with Covid 19 based on CT scan or PCR.
- •Patients with fasting blood sugar above 100 at the time of referral
- •Patients with previous diagnosis of diabetes and under treatment
- •Study and accept consent to participate in the study
- •Patients over 18 years of age
排除标准
- •Acute renal failure, chronic renal failure with stage 4,5
- •Acute and chronic liver failure
- •History of immunodeficiency diseases, using immunodeficiency drugs
- •Pregnancy and breastfeeding
- •Patients who are admitted to the intensive care unit upon arrival
- •Patients with contraindications to cytagliptin (pancreatitis and its history, diabetic gastroparesis, history of severe drug allergy)
研究者
相似试验
进行中（未招募）
1 期
Effects of linagliptin on left ventricular myocardial DYsfunction in patients with type 2 DiAbetes mellitus.Type 2 Diabetes mellitusMedDRA version: 17.1Level: HLGTClassification code 10018424Term: Glucose metabolism disorders (incl diabetes mellitus)System Organ Class: 10014698 - Endocrine disordersMedDRA version: 17.1Level: PTClassification code 10067585Term: Type 2 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: SOCClassification code 10027433Term: Metabolism and nutrition disordersSystem Organ Class: 10027433 - Metabolism and nutrition disordersMedDRA version: 17.1Level: HLTClassification code 10012602Term: Diabetes mellitus (incl subtypes)System Organ Class: 10014698 - Endocrine disordersEUCTR2014-004683-38-ITFondazione per il Tuo cuore onlus-ANMCO186
招募中
不适用
Effect of dipeptidyl peptidase-4 inhibitor to the additional secretion of insulin in type 2 diabetic patients on hemodialysisType 2 diabetic patients on hemodialysisJPRN-UMIN000006024Chibune general hospital5
已完成
不适用
Effects of dipeptidyl peptidase-4 (DPP-4) inhibitor, alogliptin, on coronary atherosclerosis in patients with type 2 diabetes mellitusPatients with type 2 diabetes mellitus who were suspected as having ischemic heart diseaseJPRN-UMIN000015381Kanagawa PTCA Conference50
已完成
不适用
The impact of dipeptidyl peptidase-4 inhibitor on coronary microvascular function in patients with type2 diabetes mellitusType 2 diabetic patients with stable angina pectoris who undergo percutaneous coronary interventionJPRN-UMIN000004390Cardiovascular Division, Hyogo College of Medicine40
已完成
不适用
Effect of DPP-4(dipeptidyl peptidase-4) inhibitor for coronary plaque in diabetes patients.JPRN-UMIN000007255Center for Cardiovascular Interventions,Chiba University Hospital128